TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Post-treatment spot urine sodium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area Under the Curve from Time 0 to Infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Newborn's pain response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Area under the curve (AUC) of dabigatran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 3 non-hematological CAR-T related toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Bi-directional block confirmation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite of serious cardiovascular adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: long-term safety profile
Endpoint domain: Adverse events/effects
Primary endpoint: Target-corrected Binocular Intermediate Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance Corrected Binocular Intermediate Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lens Densitometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expiratory flow rate during forced expiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Viral plasma load measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of pelvic inflammatory disease (PID)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean Score of Sensory Attributes Based on Palatability Assessment Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Breathing Pattern Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Radial Spasm occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Successful radial puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Parental Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parental Posttraumatic Stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of participants passing safety and benefit outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Stroke Knowledge Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change From Baseline in Mean LDL at Week 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of DRPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in DRPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of PSH
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of ECMO related bleeding or thrombotic events
Endpoint domain: Adverse events/effects
Primary endpoint: SHUEE Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Survival at 30 days post-discharge
Endpoint domain: Mortality/survival
Primary endpoint: Relapse rate 2 weeks after discharge
Endpoint domain: Mortality/survival
Primary endpoint: Relapse rate 1 month after discharge
Endpoint domain: Mortality/survival
Primary endpoint: Relapse rate 3 months after discharge
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients not diagnosed with clinically significant prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Discontinuation or change from VTD standard dosing
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of drug induced liver injury (DILI) with VTD
Endpoint domain: Adverse events/effects
Primary endpoint: Actigraphic evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Polysomnographic evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality by group at 30-day follow up
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of oral cavity cancer
Endpoint domain: Mortality/survival
Primary endpoint: Maximum Observed Concentration (Cmax) of LOXO-783
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-Time Curve (AUC [0-∞]) of LOXO-783
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of healthy nail surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in PTSD-symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Thrombotic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: self-perceived overall quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Presence of caesarean scar niche
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Dimensions of caesarean scar niche
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of subjects with proinflammatory monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Higher ER stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate of sentinel lymph node(s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Specificity of sentinel lymph node mapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Negative and positive predictive values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: total amount of tramadol consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Improvement of PTSD symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Statin lactone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of change in patient uACR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Safety of the DTwP-Hepatitis B-Hib-IPV vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity of DTwP-Hepatitis B-Hib-IPV vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Successful pleurodesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy equivalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep spindle rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Postoperative hematoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subclinical cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to first hospitalization for heart failure or cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Recurrence rate of patients
Endpoint domain: Mortality/survival
Primary endpoint: Delta Syndecan-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dental Plaque Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periodontal Bleeding Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in neuronal integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in axonal damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis accuracy of LVOCheck algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's perception of quality of care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Kinesiophobia Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Monocular refractive target accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain structure (cortical thickness) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cerebral blood flow change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Child mental health change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of days app used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Area Under the Curve (AUC 0-4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year distant recurrence-free interval
Endpoint domain: Mortality/survival
Primary endpoint: Local and Metastatic Progression Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 90 Day Post-Operative Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Release of PDGF-BB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in Weekly Vomiting Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Scoring Change in Nausea Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cardiovascular Disease Risk Awareness Rating Scale Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants experiencing a DLT
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants treated with the triple combination
Endpoint domain: Resource use
Primary endpoint: Change in level of child Glycosylated hemoglobin (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in amount of child vegetable intake as assessed by the VEGGIE METER®
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Pulsatile Tinnitus Symptom Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to achieve Oromotor skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients' Oral Health Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patients' Denture Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of study patients enrolled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of study patients randomized
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of study patients who received the study medication
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of MOM intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of the MOM intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of IOP lowering medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: AUCinf of Total Dabigatran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast of Total Dabigatran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCinf of Rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of eligible patients screened
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of time with sensor glucose in the target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Perception of Pregnancy Risk Scale (PPRS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pregnancy-related Anxiety Scale (PrAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postpartum Quality of Life Questionnaire (PQLQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Performance of the EGFR assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of HPV infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Intraoperative quantified blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Composite error scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Evolution of the inverse correlation task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight management belief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Weight management knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Safety and tolerability of BPI-28592
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants with Primary Adverse Events (PAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: diagnostic yield of tissue sampling techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in masseter muscle electromyographic activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Orofacial pain changes
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Proportion of eligible participants who complete the study protocol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Accuracy of Occlusion after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of Condylar position after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence/degree of carotid occlusive disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Optimal catheter filling volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative Number of Active Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Same day discharge rate
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Difference in eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: re-expression of SSTR2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedural pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Recurrence of vasovagal syncope
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-rTMS change in ssVEP Response Amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: post-rTMS change in visual contrast perceptual sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Vital Signs - Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vital Signs - Respiratory Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Vital Signs - Heart Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neurological examinations changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to severe hypotension resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Luna EMG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-cesarean bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: clinical utility of plasma circRNAs as a diagnostic biomarker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Versional Dysconjugacy Index (VDI) - Area Under the Curve (VDI-AUC) at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Versional Dysconjugacy Index (VDI) - Area Under the Curve (VDI-AUC) at 36 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The evolution of the plasmatic levels of CA 19-9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic fatigue symptoms
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Child Wasting Prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maternal Wasting Prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Child Mid-Upper Arm Circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Child Weight-for-Height
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tooth development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: INCAT Disability Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Muscle pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Skin biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Occurrences of any drug-related AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Red blood cell characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Angiogenesis biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal Oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Self-reported sexual function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Left ventricular thrombus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of intermetatarsal bursitis on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of intermetatarsal bursitis on US
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Visual Analogue Score (VAS) score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Proportion of subjects exhibiting No Persistent Airflow Limitation (NPAL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of subjects that remains or becomes Adequately Controlled
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and nature of adverse events and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Absence of space occupying masses on cranial MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Skills of Cognitive Therapy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of participants with inspiratory muscle dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of participants with small airway dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Adverse Events (AE) assessed by CTCAE ver5.0
Endpoint domain: Adverse events/effects
Primary endpoint: Cytopenia stabilization or improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Re-tear rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Breath hydrogen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients' experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: high-sensitivity C-reactive protein (hs-CRP) in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: biochemically-verified tobacco abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic Floor Impact Questionnaire (PFIQ-7)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The Sexual Quality of Life-Female (SQOL-F)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pelvic Floor Distress Inventory PFDI-20
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of allogeneic red blood cell products transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Acute radiation induced mucositis and dermatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Concentration of Insulin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Perihematomal oedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Specificity of AI model
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Accuracy of AI model
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Sensitivity of AI model
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of patients attempting smoking cessation
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change From Baseline in Level of Global DNA Methylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes